0.335
-0.01 (-2.9%)
-0.01 (-2.9%)
Upgrade to Real-Time
Market Closed
| Volume | 1,357,212 |
|
|||||
| News | - | ||||||
| Day High | 0.346 | Low High |
|||||
| Day Low | 0.33 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.01 | -2.9% | 0.335 | 16:08:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.34 | 0.33 | 0.346 | 0.335 | 0.345 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 371 | 1,357,212 | $ 0.335921 | $ 455,916 | - | 0.2311 - 1.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:05:54 | average | 122,000 | $ 0.33485 | USD |
Period:
Draw Mode:
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 272.91M | 814.64M | 556.02M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 33.93M | $ - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3451 | 0.375 | 0.33 | 0.3513302 | 689,697 | -0.0101 | -2.93% |
| 1 Month | 0.348 | 0.4345 | 0.3101 | 0.3671644 | 1,145,326 | -0.013 | -3.74% |
| 3 Months | 0.61 | 0.63 | 0.3101 | 0.4223015 | 1,168,798 | -0.275 | -45.08% |
| 6 Months | 0.331 | 1.30 | 0.31 | 0.6157231 | 1,890,519 | 0.004 | 1.21% |
| 1 Year | 1.12 | 1.30 | 0.2311 | 0.5891998 | 2,308,468 | -0.785 | -70.09% |
| 3 Years | 0.293 | 10.01 | 0.2311 | 2.71 | 3,727,552 | 0.042 | 14.33% |
| 5 Years | 0.61 | 10.01 | 0.0552 | 2.56 | 2,411,410 | -0.275 | -45.08% |
CytoDyn (QB) Description
| CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. |